Document is current
Any future updates will be listed below
-
Authors
Oikonomidou, P. R.
Casu, C.
Yang, Z.
Crielaard, B.
Shim, J. H.
Rivella, S.
Vogiatzi, M. G.
-
Funding
Funding for this research was provided by:
National Institutes of Health (K08 HL088231, R01DK095112, R01DK090554)
- License Information
-
More Information
Article History
Received: 22 September 2015
Accepted: 5 November 2015
First Online: 9 December 2015
Compliance with Ethical Standards
:
: All applicable institutional and/or national guidelines for the care and use of animals were followed. All procedures performed were in accordance with the ethical standards of Weill Cornell Medical College at which the studies were conducted. All studies were approved by the Institutional Animal Care and Use Committees of Weill Cornell Medical College.This article does not contain any studies with human participants performed by any of the authors.
: Dr. Rivella is a consultant for Novartis Pharmaceuticals, Isis Pharmaceuticals, Medgenics Pharmaceuticals, and Bayer Healthcare.Paraskevi-Rea Oikonomidou, Carla Casu, Zhiwei Yang, Bart Crielaard, Jae-Hyuck Shim, and Maria G. Vogiatzi declare that they have no conflict of interest.
